On the other hand, activation of TNFR2 by agonistic antibodies or agonistic TNF muteins that activate, stabilize, and expand Tregs [15, 126] could have considerable therapeutic implications for treatment of autoimmune liver disease. The gene discussed is TNFRSF1B; the disease is autoimmune hepatitis.